Diazoxide Suppression Test P&F Study
NCT06606327
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Insulin Resistance
Hyperinsulinemia
Obesity
Interventions
DRUG:
Diazoxide, 3 mg/kg per dose
Sponsor
Columbia University
Collaborators
[object Object]
[object Object]